2018 Conference on Retroviruses and Opportunistic Infections (CROI)

Protocol

Title

Authors

Presentation Type

Monday, 5 March

PROMISE 1077BF/FF/HS

HIV-1 viral rebound and safety outcomes of postpartum treatment interruption in women

Le CN, Britto P, Brummel S, Hoffman RM, Flynn PM, Taha TE, Coletti A, Fowler MG, Klingman KL, McIntyre JA, Li JZ, Currier JS

Poster

Lab

A two-dimensional approach to analyzing broadly neutralizing antibody combinations

Webb NE, Sevaried CM, Tobin NH, Aldrovandi GM

Poster

PROMISE 1077HS	Predictors of virologic failure in postpartum women on ART in PROMISE 1077HS	Hoffman RM, Warshaw M, Amico KR, Pilotto JH, Masheto G, Achalapong J, Machado ES, Chokephaibulkit K, Duarte G, Coletti A, Browning R, Chakhtoura N, Klingman K, and Currier JS, for the PROMISE 1077HS team	Poster
P1101	Phase I/II study of a raltegravir-containing regimen in HIV-infected children with TB	Meyers T, Krogstad P, Samson P, Acosta EP, Moye J, Townley E, Bradford S, Marillo L, Hovind L, Sise T, Teppler H, Dittmer S, Fairlie L, Hesseling AC, Cotton MF	Poster
P1106	Pharmacokinetics and safety of lopinavir/ritonavir solution in HIV-infected newborns	Bekker A, Hanan N, Cababasay M, Wang J, Nakwa F, Smith E, Moye J, Violari A, Cotton M, Wiesner L, Norman J, Fourie B, Capparelli EV, Mirochnick M, IMPAACT P1106 team	Poster

Tuesday, 6 March

P1104s

African multi-site 2-year study of neurocognition in HIV infected/affected children

Boivin MJ, Chernoff M, Laughton B, Zimmer B, Joyce C, Barlow-Mosha L, Bwakura-Dangarembizi M, Ratswana M, Fairlie L, Kamthunzi P, McCarthy K, Jean-Philippe P, Violari A, Cotton M, Palumbo P

Poster

NWCS 612/ P1072

Intestinal damage and inflammation in perinatally HIV-1-infected African infants

Koay WA, Lindsey JC, Uprety P, Weinberg A, Levin MJ, Bwakura-Dangarembizi M, Persaud D

Poster

P1090

Etravirine pharmacokinetics in treatmentexperienced HIV-infected children ≥12 mos to <6 yrs

MacBrayne CE, Rutstein R, Yogev R, Wiznia A, Fairlie L, Graham B, Alvero C, Moye J, Townley E, Crauwels H, Woot de Trixhe X, Tambuyzer L, Vanveggel S, Opsomer M, Kiser JJ

Poster

Wednesday, 7 March

PROMISE 1077BF/FF

Hoffman RM, Angelidou K, Brummel SS, Saidi F, Violari A, Dula D, Mave V, Fairlie L, Theron G, Kamateeka M, Chipato T, Klingman K, Chakhtoura N, Currier JS, Fowler MG, for the PROMISE 1077BF/FF team

Oral presentation

PROMISE 1077BF

PROMISE trial: Results of continued vs discontinued ART after end of breastfeeding

Taha TE, Brummel S, Angelidou K, Fowler MG, Flynn PM, Mukuzunga C, Dula DE, Owor M, Moodley D, Chipato T, Loftis AJ, Chakhtoura N, McCarthy K, Currier JS, for the IMPAACT PROMISE Study Team

Oral presentation

P1078	Randomized trial of safety of isoniazid preventive therapy during or after pregnancy	Gupta A, Montepiedra G, Aaron L, Theron G, McCarthy K, Onyango-Makumbi C, Chipato T, Masheto G, Shin K, Zimmer B, Sterling TR, Chakhtoura N, Jean-Philippe P, Weinberg A, for the IMPAACT P1078//TB APPRISE Study Team	Oral presentation
Lab	Pregnancy associated vaginal proteome alterations linked to HIV acquisition risks	Zuend CF, Tobin N, Birse K, Noël-Romas L, Vera T, Kotyrba L, Mutch S, Abo M, McCorrister S, Westmacott G, Aldrovandi GM, Burgener A	Poster
NWCS 121	Infant HIV vaccination: relationship to childhood vaccines and maternal antibodies	Itell H, McGuire E, Chen M, Muresan P, Permar S, and Fouda G	Poster
NWCS 116/ P1025	Markers of preterm delivery in HIV+ women; Role of protease inhibitors and vitamin D	Weinberg A, Huo Y, Kacanek D, Patel K, Watts H, Wara D, Klawitter J, Christians U, for IMPAACT Team P1025	Poster